Funding for this research was provided by:
Defense Advanced Research Projects Agency (B08006)
National Major Science and Technology in Key New Drugs Creation (2012ZX09104-203)
Text and Data Mining valid from 2020-02-13
Received: 27 December 2018
Accepted: 22 January 2020
First Online: 13 February 2020
Ethics approval and consent to participate
: The study protocol was approved by the Medical Ethics Committee of Beijing Anzhen Hospital and the Medical Ethics Committee of the study institutions where this study was conducted. Written informed consent was provided by the patients and their legal representatives.
: Not applicable.
: XF Liu, F Sun are employees of Zhongjing Wanxi Pharmaceutical Co., Ltd, Zhongjing Wanxi Pharmaceutical Co., Ltd supplied the study drugs for this clinical trial, other authors declare that they have no competing interests.